ArticleEuropean radiology2026
Independent bone-level diagnostic accuracy study of an AI tool for detecting appendicular skeletal fractures on radiographs.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Fracture Detection on Bone Radiographs: The Impact of an AI Tool on Orthopaedic Night Shifts.Journal of imaging · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesTo perform an in-depth evaluation of the diagnostic test accuracy of a commercially available AI tool for assistance in fracture detection on radiographs. MATERIALS AND
methodsThis retrospective study included consecutive patients with trauma radiographs at seven Danish hospitals. The AI output was evaluated using the clinical radiologic report as a reference standard for a binary fracture outcome. The report is based on assessments by an emergency physician, a senior orthopedic surgeon, and a radiology expert. Sensitivity, specificity, positive- and negative predictive values were calculated. Sensitivity and specificity were additionally stratified for children, degenerative disease, metal, old fractures, casting, obvious fractures, and inter-hospital differences. Bone-wise sensitivity and specificity were assessed for multiple fracture cases and individual bones.
resultsThe study sample consisted of 2783 patients (median age 38 years, IQR, 21, 64, 1443 female), and 948 (34%) had the target finding. The AI tool demonstrated an overall sensitivity of 89% (95% CI: 87%-91%) and specificity of 88% (95% CI: 86%-89%). The specificity was 57% (95% CI: 49%-65%) in examinations with old fractures. Bone-wise sensitivity for carpal fractures ranged from other carpals 25% (95% CI: 1%-81%] to triquetrum 75% (95% CI: 43%-95%). Tarsal fractures ranged from medial cuneiform 0% (95% CI: 0%-60%) to talus 53% (95% CI: 27%-79%).
conclusionThe AI tool demonstrated high overall diagnostic accuracy and performed robustly across most specific situations. However, specificity was substantially reduced in the presence of old fractures. The bone-wise analysis showed great variability, with a pattern of poor accuracy for short, irregular bones. KEY POINTS: Question Can a commercially available AI tool reliably detect fractures across anatomical regions, confounding factors, and individual bones -and are there patterns in diagnostic limitations? Findings The AI tool achieved 89% sensitivity and 88% specificity with consistent accuracy across subgroups. However, accuracy dropped for old fractures and irregular short bones. Clinical relevance Despite broad regulatory approval, AI fracture tools may overlook clinically relevant weaknesses. Our in-depth evaluation highlights limitations, guiding responsible clinical use and future research to support safe AI implementation in radiology and informed medicolegal regulation.
Indexed as
Identifiers
41995742What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.